Synthesis of Simple Enantiopure Tetrahydro-β-carbolines and Tetrahydroisoquinolines

From imine to amine: an unexpected left turn. Cis-β iron(ii) PNNP' precatalysts for the asymmetric transfer hydrogenation of acetophenone

A slight change in the iron catalyst structure (amine arm with PEt₂ to imine arm with PPh₂) results in a complete reversal of the enantioselectivity toward ketone reduction.

A novel PNN ligand bearing an orthophenylene group and a primary amine was synthesized with the aid of a palladium-catalyzed amination and reacted with phosphonium dimers [–PR₂CH₂CH(OH)–]₂[Br]₂ R = Et, iPr, Cy, Ph, xylyl, and o-Tol, and [Fe(OH₂)₆]²⁺ to produce a new series of cis-β iron(ii) PNNP′ precatalysts cis-β-[Fe(Br)(CO)(PNNP′)]BPh₄ as a pair of diastereomers. The more stable orthophenylene amido group was chosen to imitate and replace the enamido moiety of a highly active iron precatalyst for the asymmetric transfer hydrogenation (ATH) of ketones in an attempt to prevent its deactivation caused by reduction of the enamido group. This objective was partially achieved using the complex with a PEt₂ group which catalyzed the transfer hydrogenation in isopropanol of 150 000 equivalents of acetophenone to racemic 1-phenylethanol. With a low acetophenone to catalyst ratio of 500 to 1, the catalytic activity was moderate and the enantiomeric excess (ee) of the product 1-phenylethanol ranged surprisingly from 94% (R) to 95% (S) depending on the nature of PR₂ and whether the precatalyst contained an imine or amine donor. The amine precatalyst with a PEt₂-group produced a more stable hydride species when activated, allowing the reaction mixture to be heated to 75 °C to obtain a TON of 8821 for acetophenone while retaining the high ee of 95% (S). The activation pathway in basic isopropanol (iPrOH) was studied for three precatalysts to elucidate that the cis-β precatalysts rearrange to form trans hydride complexes. The study suggests that the enantioselectivity of these complexes is determined by from which side of the PNNP′ plane the hydride transfer occurs.

N-Heterocyclic carbene-catalyzed annulation of cyclic β-enamino esters with enals: access to functionalized indolo[2,3-a]quinolizidines

A novel synthetic approach to functionalized indolo[2,3-a]quinolizidines is developed via an N-heterocyclic carbene-catalyzed annulation of cyclic β-enamino esters with enals.

Enantioselective synthesis of indoloquinolizidines via asymmetric catalytic hydrogenation/lactamization of imino diesters

We have developed a highly efficient cascade sequence for asymmetric synthesis of indoloquinolizidines with absolute control of cis-H2/H12b relative geometry in good to excellent yields and excellent enantioselectivities. This cascade was triggered by the Ru(II)-TsDPEN-catalyzed asymmetric transfer hydrogenation of imino diesters, with subsequent spontaneous lactamization with discrimination between the two diastereotopic 2-alkoxy-2-oxoethyl groups. The synthetic utility of this strategy was demonstrated by the asymmetric preparation of dihydrocorynantheol, geissoschizol, and isogeissoschizol.

Opportunities offered by chiral η⁶-arene/N-arylsulfonyl-diamine-RuII catalysts in the asymmetric transfer hydrogenation of ketones and imines

Methods for the asymmetric transfer hydrogenation (ATH) of ketones and imines are still being intensively studied and developed. Of foremost interest is the use of Noyori's [RuCl(η⁶-arene)(N-TsDPEN)] complexes in the presence of a hydrogen donor (i-PrOH, formic acid). These complexes have found numerous practical applications and have been extensively modified. The resulting derivatives have been heterogenized, used in ATH in water or ionic liquids and even some attempts have been made to approach the properties of biocatalysts. Therefore, an appropriate modification of the catalyst that suits the specific requirements for the reaction conditions is very often readily available. The mechanism of the reaction has also been explored to a great extent. Model substrates, acetophenone (a ketone) and 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline (an imine), are both reduced by this Ru catalytic system with almost perfect selectivity. However, in each case the major product is a different enantiomer (S- for an alcohol, R- for an amine when the S,S-catalyst is used), which demanded an in-depth mechanistic investigation. Full-scale molecular modelling of this system enabled us to visualize the plausible 3D structures of the transition states, allowing the proposition of a viable explanation of previous experimental findings.

An asymmetric formal synthesis of fasicularin

An asymmetric formal synthesis of fasicularin (1) is described. This natural product, isolated from the extracts of the marine invertebrate Nephteis fasicularis, has shown modest cytotoxicity towards Vero cells. Fasicularin is among only two members of the cylindricine family of natural products, along with lepadiformine (2), to possess a trans A-B ring junction. Key steps of this approach to 1 involve a siloxy-epoxide semipinacol rearrangement of 5 to 6, a B-alkyl Suzuki-Miyaura coupling reaction by using enol trifluoromethanesulfonate 19 and a substrate-directed hydrogenation reaction of 24. This formal synthesis also highlights the difficulty in the incorporation of the thiocyanate functionality present in 1.

Asymmetric transfer hydrogenation of imines and iminiums catalyzed by a water-soluble catalyst in water

The first asymmetric transfer hydrogenation of cyclic imines and iminiums in water was successfully performed in high yields and enantioselectivities with sodium formate as the hydrogen source and CTAB as an additive catalyzed by a water-soluble and recyclable ruthenium(II) complex of the ligand (R,R)-2.

Synthesis and biological evaluation of new tetrahydro-β-carbolines as inhibitors of the mitotic kinesin Eg5

The mitotic kinesin Eg5 (or KSP) is a crucial player in the development and function of the mitotic spindle. Inhibition of this protein leads to cell cycle arrest and apoptosis without interfering with other microtubule-dependent processes. Therefore, it is a potential target in cancer therapy. Here, we report the synthesis and biological evaluation of a small library of molecules based on the structure of the known Eg5 inhibitor HR22C16. One of these derivatives (compound trans-24) proved to be a potent and specific Eg5 inhibitor.

Catalytic N-Sulfonyliminium Ion-Mediated Cyclizations to α-Vinyl-Substituted Isoquinolines and β-Carbolines and Applications in Metathesis

[reaction: see text] Catalytic Sn(OTf)2-induced cyclization of linear, aryl-containing allylic N,O-acetals produced vinyl-substituted tetrahydroisoquinolines and tetrahydro-1H-beta-carbolines. The usefulness of the vinyl moiety in the resulting products was demonstrated via the synthesis of various key building blocks for alkaloid structures. The alpha-vinyl moiety was utilized in a [2,3] sigmatropic rearrangement, in ring-closing metathesis and a cross-metathesis-based synthesis of vincantril, an antianoxia agent, and a synthetic member of the vincamine type natural products.

One-pot formation of nitrogen-containing heterocyclic ring systems using a deprotection–cyclisation–asymmetric reduction sequence

A one-pot sequence of amine deprotection, intramolecular C=N bond formation and subsequent asymmetric reduction may be promoted by a ruthenium catalyst.

Enantioselective total syntheses of (+)-arborescidine A, (-)-arborescidine B, and (-)-arborescidine C

Described are the first enantioselective total syntheses of (+)-arborescidine A ((+)-1), (-)-arborescidine B ((-)-2), and (-)-arborescidine C ((-)-3), via routes that proceeded in five steps and 50% overall yield, eight steps and 61% overall yield, and nine steps and 51% overall yield, respectively, from 6-bromotryptamine (7). The syntheses feature the use of the Noyori catalytic asymmetric hydrogen-transfer reaction to introduce chirality in dihydro-beta-carbolines 6 and 8. On the basis of an ample precedent from Noyori's work, the reduction produces dihydro-beta-carbolines, and ultimately the natural products, possessing the R absolute configuration. The synthetic arborescidines displayed optical rotations that were opposite in sign those of the natural products, thereby supporting the S configuration for natural arborescidines A (1) and B (2) and the (3S,17S) configuration for natural arborescidine C (3). Our results are in agreement with the initial stereochemical assignment by Païs and co-workers, and are counter to their recently revised assignment.

Differential effects of synthetic indoloquinolizines on in vitro rat lymphocyte and macrophage functions

Indoloquinolizines are natural alkaloid indole products grouped as beta-carbolines. These compounds are commonly associated with neurological activities, but little is known about their role as immunomodulating agents. The present study was undertaken to evaluate the effects of synthetic indoloquinolizines on in vitro parameters of rat lymphocyte and macrophage functions. It was observed that proliferation of thymic lymphocytes was significantly (p<0.05) increased (20-30% increase) by dihydro-indoloquinolizinium chloride (2). dihydro-indoloquinolizinyl-ethanone (3). and dimeric dihydro-indoloquinolizinium dichloride (6). whereas dimeric indoloquinolizine (7). caused up to 40% increase in lymphoproliferation at concentrations ranging from 10(-11) to 10(-5) M, compared with untreated control. In contrast, indoloquinolizinium chloride (4) and indoloquinolizine (5). were toxic for lymphocytes at concentrations from 10(-9) to 10(-5) M, and compounds 6 and 7 were toxic at 10(-5) M. In addition, nitric oxide production by LPS-treated peritoneal macrophages was significantly (p<0.05) increased (up to 30% increase) by compounds 4 and 5 at concentrations of 10(-11) to 10(-5) M, and 10(-5) M, respectively; however, compounds 6 and 7 were toxic for macrophages at all concentrations tested. Furthermore, TNF-alpha production was also significantly increased (p<0.01) by compounds 4 and 5 (up to 30-fold increase) compared with untreated control. These novel synthetic indoloquinolizines could serve as immunotherapeutic agents by selectively increasing the pool of activated T lymphocytes or stimulating macrophage functions, with potential use in the treatment of infectious diseases including AIDS and cancer.